HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched its over-the-counter (OTC) Fexofenadine HCl and Pseudoephedrine HCl extended release ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

Details concerning the Fexofenadine HCl combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids ...

Dr Reddy’s Laboratories has launched its over-the-counter (OTC) fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release tablets 60 mg / 120 mg, a bioequivalent generic version of ...

Hyderabad-based Dr. Reddy's Laboratories today said that it had entered the $452 million Fexofenadine market with the launch of its over-the-counter fexofenadine hydrochloride tablets. The ...

Dr. Reddy’s is offering the first to market over-the-counter fexofenadine HCl 180 mg and pseudoephedrine HCl 240 mg extended-release tablets, a store-brand equivalent of Aventis’s Allegra-D 24 HR.

ALLEGAN, Mich., April 13, 2011 /PRNewswire/ -- Perrigo (Nasdaq: PRGO;TASE) today announced that its partner, Teva Pharmaceutical Industries, Ltd. (Nasdaq: TEVA), has received final OTC approval to ...

Dr. Reddy’s Laboratories announced the launch of Fexofenadine HCl and Pseudoephedrine HCl Extended Release Tablets, the generic version of Chattem’s Allegra-D 12 Hour. Allegra-D 12 Hour is a ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...

Dr Reddy’s Laboratories Ltd., an integrated pharmaceutical company, announced the first-to-market launch of the US Food and Drug Administration (FDA) approved over-the-counter (OTC) fexofenadine HCl ...

Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated November 20, 2014, titled "Dr. Reddy’s announces the Launch of Over-the-Counter Fexofenadine Hydrochloride 60 mg and ...